From July 1, 2020 to September 30, 2020, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 69,714 shares, representing 0.11% for KRW 918.87 million under the buyback announced on March 13, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,555 KRW | -2.11% | -22.46% | -17.31% |
05-20 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
05-20 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.31% | 160M | |
-27.70% | 9.87B | |
+27.06% | 2.89B | |
-16.78% | 2.75B | |
-15.31% | 2.13B | |
-21.41% | 1.65B | |
+68.70% | 1.47B | |
+29.75% | 811M | |
-5.02% | 733M | |
-29.39% | 510M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.